Clinical Trial Detail

NCT ID NCT00520130
Title Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

hematologic cancer

Therapies

Cytarabine + Fludarabine

Alemtuzumab + Cyclosporine

Cyclophosphamide + Doxorubicin + Etoposide + Fludarabine + Prednisone + Rituximab + Vincristine Sulfate

Cyclophosphamide + Doxorubicin + Etoposide + Fludarabine + Prednisone + Vincristine Sulfate

Methotrexate + Sirolimus + Tacrolimus

Filgrastim

Age Groups: child adult

No variant requirements are available.